Cashu | News | JNJ

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Stocks

Health Care

jnj

Johnson & Johnson

NYSE: JNJ

+2.58 (+1.57%)

167.32

USD

At close at Aug 01, 20:34 UTC

Latest Johnson & Johnson News

Trump's drug price ultimatum sets pharma firms scrambling

Feature Image for interests on Biotech And Pharmaceuticals, Biotechnology, Business, Computing from cnbc.com

What's Going On With Eli Lilly Stock On Tuesday?

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report

Feature Image for interests on Healthcare, News, Stock, Unknown Sector from benzinga.com

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

Feature Image for interests on Clinical Trials & Medical Discoveries, Fda Approval, Health Care & Hospitals, Healthcare from prnewswire.com

Why a great company's beat and raise was sold, and what I plan to do with the stock

Feature Image for interests on Basic Materials, Breaking News: Markets, Consumer Cyclical, Healthcare from cnbc.com

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Feature Image for interests on ETF, Etfs, Healthcare, Sector Etfs from benzinga.com

3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs

Feature Image for interests on Financial Services, Healthcare, Opinion, Stock from benzinga.com

Johnson & Johnson showcases latest advancements in Alzheimer's research at AAIC 2025

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Financial Services, Health Care & Hospitals from prnewswire.com

European Commission Approved DARZALEX Faspro for Adult Patients with Smouldering Multiple Myeloma

Feature Image for interests on Healthcare, International Medical Approval, Stock from prnewswire.com

Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Latest Cashu News

Johnson & Johnson (JNJ) Submits TREMFYA® for Psoriatic Arthritis Treatment Advancement

Johnson & Johnson: Leading the Charge in Sustainable Innovation and Healthcare Solutions

Johnson & Johnson: Honeywell Restructures to Strengthen Market Position Amid Underperformance